UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in BIIB — Biogen Inc.
CIK 861177
NEW YORK, NY
Position in BIIB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$271,191,591
+$18,642,055 QoQ
Shares Held
1,255,168
-8.9% QoQ
Ownership
0.850%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#18
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $25,598,342,767 across 16 Drug Manufacturers - General names. BIIB ranks #9 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,209,385 | $8,647,153,365 | |
| 2 | JNJ |
Johnson & Johnson
|
18,416,123 | $4,677,142,752 | |
| 3 | ABBV |
AbbVie Inc.
|
14,267,697 | $3,590,323,267 | |
| 4 | MRK |
Merck & Co., Inc.
|
19,547,171 | $2,511,811,470 | |
| 5 | AMGN |
Amgen Inc
|
5,390,910 | $1,952,156,323 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
12,986,591 | $1,640,725,902 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
22,839,010 | $1,315,983,749 | |
| 8 | PFE |
Pfizer Inc
|
36,157,306 | $870,667,923 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $271,191,591 | 1,255,168 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $252,549,536 | 1,377,568 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $244,867,203 | 1,391,370 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $201,604,250 | 1,439,208 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $218,929,612 | 1,743,209 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $206,681,214 | 1,510,386 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $234,550,679 | 1,533,813 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $223,437,617 | 1,152,691 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $262,834,264 | 1,133,786 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $209,623,189 | 972,143 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $262,543,637 | 1,014,583 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $273,848,774 | 1,065,518 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $317,494,374 | 1,114,602 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $309,892,789 | 1,114,602 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $303,003,366 | 1,094,191 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $298,093,752 | 1,116,456 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $236,012,210 | 1,157,263 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $244,993,503 | 1,163,312 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $278,139,731 | 1,159,302 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $352,318,582 | 1,244,986 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $394,219,039 | 1,138,473 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $324,449,570 | 1,159,784 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $291,480,605 | 1,190,397 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $377,194,537 | 1,329,648 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $350,161,678 | 1,308,771 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $346,264,617 | 1,094,458 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||